Advertisement

Picture biomindz Brand LSE Mainz Place to Biotech 650x100px
Organisation › Details

Absci Corporation (Nasdaq: ABSI)

AbSci is a leading synthetic biology company focused on redefining protein biomanufacturing. We are making protein production as simple as DNA synthesis through our revolutionary Protein Printing™ technology. AbSci enables a pathway to commercialization for biologics that otherwise wouldn’t get to market due to poor manufacturability. Our mission is to improve patients’ lives by reducing drug costs, accelerating development timelines, and enabling new biologic therapies to market. *

 

Period Start 2011-01-01 established (s-off)
  Predecessor AbSci LLC
Product Industry  synthetic biotechnology
     
  City n. a. 
    Address record changed: 2023-11-16
     
Basic data Employees n. a.
     
    * Document for »About Section«: AbSci, LLC. (10/20/20). "Press Release: AbSci Announces $65 Million Financing Led by Casdin Capital". Vancouver, WA.
     
   
Record changed: 2023-11-16

Advertisement

Picture biomindz TRON LSE Mainz Translation Cancer Immunotherapy 650x200px

More documents for Absci Corporation (Nasdaq: ABSI)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture biomindz Brand LSE Mainz Place to Biotech 650x300px




» top